PubMed Health⌕ Search

Biomedical subjects

S D Edland

Publications and source records attributed to S D Edland.

38 records · Page 3Linked to original sources

Mixed effect models of longitudinal Alzheimer's disease data: a cautionary note.

Longitudinal studies of cognitive function in Alzheimer's disease (AD) patients are powerful tools to better understand the biology and natural history of the disease, but the attributes of the studies that make them valuable also pose special challenges to analysts. A fundamental problem is the accurate measure of time at which cognitive decline begins. Investigators typically use the date of AD diagnosis or the date of enrollment in an AD study. If the rate of cognitive decline is non-linear, variables associated with the time of diagnosis or enrollment might artificially be associated with the rate of decline. Unlike the mixed effects models typically used to analyse cognitive decline, summary measure analyses do not directly compare the rate of decline with time since decline began, and, therefore, are less sensitive to biased measures of time of decline. We simulated trajectories of cognitive decline using the multivariate normal random effect model and tested the ability of the two analytic techniques to discriminate between true and spurious associations. Our analyses suggest summary measure models are less likely to detect spurious associations generated by biased measures of time at which decline begins, and more likely to detect true associations concealed by biased time measurement.

Aged↗

Trypsin inhibitor activities of fibroblasts increase with age of donor and are unaltered in familial Alzheimer's disease.

Increasing evidence suggests that proteases and their inhibitors play an important role in the etiology of beta-amyloidogenesis and Alzheimer's disease (AD). It is not clear, however, which proteases and protease inhibitors are responsible for the amyloidogenic proteolysis. Candidates include alpha-1-antichymotrypsin, inter-alpha-trypsin inhibitor, and forms of beta-amyloid precursor protein (beta PP) bearing Kunitz protease inhibitor domains. As one approach to this question, we have determined the trypsin inhibitor activity of fibroblast-like cells from 10 familial AD subjects and 20 controls. The activity was quantitated by measuring remaining trypsin activity of reaction mixtures containing trypsin and cell lysates using a fluorogenic substrate and two physiologically distinct populations of fibroblasts: proliferating cells (grown in the presence of 16% serum) and quiescent cells (maintained in 0.1% serum). The remaining trypsin activities of crude protein extracts from proliferating and quiescent AD cultures were not significantly different from those of controls. Perhaps of more general interest to the biology of aging, however, was our finding that protease inhibitor activity increased with the age of the donor (p = 0.005).

Adult↗